EquityBulls

Latest News

Regency Ceramics Ltd kickstarts its revival, commences product deliveries in Chennai
Cigniti Technologies Recognized as a Leader in Everest Group's Quality Engineering Services PEAK Matrix® Assessment 2023
SBI raises Rs. 10,000 crores through 4th infrastructure bond issue
Technical Wrap - Sep 22, 2023 - HDFC Securities
Federal Bank Hosted a Cricket Extravaganza: ICC Men's Cricket World Cup Trophy Tour Arrived with a Bang!

Keywords Selected: FinalApproval

Stock Report

Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%
Caplin Steriles gets USFDA approval for Norepinephrine Bitartrate Injection
Zydus receives final approval from the USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day
Zydus receives final approval from the USFDA for Erythromycin Tablets USP, 250 mg and 500 mg
Zydus receives final approval from the USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg
Ajanta Pharma Ltd receives final approval from US FDA for Topiramate Extended Release Capsules
Zydus receives final approval from the USFDA for Zinc Sulfate Injection Pharmacy Bulk Package Vials
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)
Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%
Eugia Pharma receives USFDA Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe
Eugia Pharma receives USFDA Approval for Vancomycin Hydrochloride for Injection USP, 1.25 g/vial and 1.5 g/vial, Single-Dose vials
Zydus receives Final Approval from the USFDA for Indomethacin Suppository with Competitive Generic Therapy designation
Aurobindo Pharma receives USFDA Approval for Saxagliptin Tablets, 2.5 mg and 5 mg
Glenmark Pharmaceuticals receives ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg
Zydus receives final approval from the USFDA for Plerixafor Injection USP, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial
Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial
Marksans announces FDA approval of OTC equivalent of Advil Dual Action Tablets
Zydus receives final approval from the USFDA for Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg
Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg
Zydus receives final approval from the USFDA for Diclofenac Sodium and Misoprostol Delayed Release Tablets
Zydus receives final approval from the USFDA for Varenicline Tablets
Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP
Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg
Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg